Patent · US Active

Therapeutic regimens

US9555014B2 · kind B2 · utility

3Cited by
39References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 19, 2014
Grant dateJan 31, 2017
Priority date—
Expiry dateMay 19, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to clinically useful therapeutic regimens comprising the administration of (R)-6-(2-(ethyl(4-(2-(ethylamino)ethyl)benzyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.